TRIB

Trinity Biotech
TRIB

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $6.51M invested in Trinity Biotech in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

53% less call options, than puts

Call options by funds: $8K | Put options by funds: $17K

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1
+$26.2K
2
+$16.5K
3
+$9.5K

Top Sellers

1
-$392K
2
-$44.4K
3
-$16.9K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13K
5
AC
Aristides Capital
Kentucky
-$11.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.81M
2
$1.66M
3
$1.38M
4
$741K
5
$405K
6
$217K
7
$99.5K
8
$38.4K
9
$34K
10
$29.9K
11
$26.8K
12
$25.7K
13
$16.8K
14
$16.5K
15
$12K
16
$1.19K
17
$962
18
$466
19
$99
20
$4
21
–
22
–
23
–